Efficacy and Safety of the Combination of Encorafenib/cetuximab with or Without Binimetinib in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer: an AGEO Real-World Multicenter Study
ESMO Open(2024)
Key words
colorectal cancer,BRAF V600E mutation,encorafenib,targeted therapy,real-world study
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined